Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S0.56
P/E—
Fwd P/E6.88
PEG1.11
52W— – —
RSI—
Target$204.24 (+21.5%)
Beta1.07
Div0.48%
Loading chart…
RSI (14)
Loading patterns…
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 68
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
2Bullish
2Bearish
0Neutral
▲ Double Bottom — Two lows ~$140.17 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$141.32 — bullish reversal confirmed
▼ Double Top — Two peaks ~$186.66 — bearish reversal confirmed
▼ Bear Flag — Breakdown after -14% pole — bearish continuation
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
75%
6/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$204.24
+21.5% upside
Low $162
—
High $310
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal-Weight | — | ↔ Maintain | 2026-07-29 |
| Guggenheim | Buy | — | ↔ Maintain | 2026-07-29 |
| Cantor Fitzgerald | Neutral | — | ↔ Reiterate | 2026-07-29 |
| Baird | Neutral | — | ↔ Maintain | 2026-07-29 |
| Barclays | Equal-Weight | — | ↔ Maintain | 2026-07-28 |
| Wells Fargo | Equal-Weight | — | ↔ Maintain | 2026-07-13 |
| TD Cowen | Buy | — | ↔ Maintain | 2026-06-22 |
| UBS | Buy | — | ↔ Maintain | 2026-04-30 |
| RBC Capital | Sector Perform | Sector Performer → Sector Perform | ↔ Maintain | 2026-04-29 |
Morgan Stanley
2026-07-29
Equal-Weight
↔ Maintain
Guggenheim
2026-07-29
Buy
↔ Maintain
Cantor Fitzgerald
2026-07-29
Neutral
↔ Reiterate
Baird
2026-07-29
Neutral
↔ Maintain
Barclays
2026-07-28
Equal-Weight
↔ Maintain
Wells Fargo
2026-07-13
Equal-Weight
↔ Maintain
TD Cowen
2026-06-22
Buy
↔ Maintain
UBS
2026-04-30
Buy
↔ Maintain
RBC Capital
2026-04-29
Sector Perform
(from Sector Performer)
↔ Maintain
Profitability
Gross Margin
44.61%TTM
Op. Margin
11.14%TTM
ROE
20.95%TTM
Rev. Growth
8.30%YoY
Free Cash Flow
497.97MTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
68.74MRQ
Current Ratio
1.12MRQ
Cash
138.80MMRQ
Total Debt
5.26BMRQ
Net Debt
—MRQ
Income
Div. Yield
0.48%TTM
Annual Rate
0.80Fwd
Payout Ratio
3.27%TTM
Dividend History
Payout Ratio (TTM): 3.27%
| Date | Amount / Share | Yield at Payment |
|---|---|---|
| 2026-06-08 | $0.2000 | 0.14% |
| 2026-03-02 | $0.2000 | 0.10% |
| 2025-12-01 | $0.2000 | 0.08% |
| 2025-09-02 | $0.2000 | 0.11% |
| 2025-06-02 | $0.2000 | 0.11% |
| 2025-03-03 | $0.2000 | 0.11% |
| 2024-12-03 | $0.2000 | 0.10% |
| 2024-09-03 | $0.2000 | 0.09% |
| 2024-06-03 | $0.2000 | 0.11% |
| 2024-02-29 | $0.2000 | 0.12% |
| 2023-11-30 | $0.2000 | 0.15% |
| 2023-08-31 | $0.2000 | 0.15% |
| 2023-05-31 | $0.2000 | 0.15% |
| 2023-02-28 | $0.2000 | 0.15% |
| 2022-11-30 | $0.2000 | 0.15% |
| 2022-08-31 | $0.2000 | 0.21% |
| 2022-05-31 | $0.2000 | 0.16% |
| 2022-02-28 | $0.2000 | 0.14% |
| 2021-11-30 | $0.2000 | 0.17% |
| 2021-08-31 | $0.2000 | 0.13% |
| 2021-06-01 | $0.2000 | 0.13% |
| 2021-03-12 | $0.2000 | 0.15% |
| 2020-02-28 | $0.2000 | 0.17% |
| 2019-12-04 | $0.2000 | 0.15% |
| 2019-08-30 | $0.2000 | 0.14% |
| 2019-05-31 | $0.1000 | 0.09% |
| 2019-02-28 | $0.1000 | 0.07% |
| 2018-11-30 | $0.1000 | 0.07% |
| 2018-08-31 | $0.1000 | 0.08% |
| 2018-05-31 | $0.1000 | 0.09% |
| 2018-02-28 | $0.1000 | 0.09% |
| 2017-11-30 | $0.1000 | 0.10% |
| 2017-08-30 | $0.1000 | 0.10% |
| 2017-05-30 | $0.1000 | 0.09% |
| 2017-02-27 | $0.1000 | 0.08% |
| 2016-11-29 | $0.1000 | 0.09% |
| 2016-08-30 | $0.1000 | 0.09% |
| 2016-05-27 | $0.1000 | 0.08% |
| 2016-02-26 | $0.1000 | 0.09% |
| 2015-11-27 | $0.1000 | 0.08% |
How UHS Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 10.18B |
| Enterprise Value | 15.30B |
| Trailing P/E | 6.78 |
| Forward P/E | 6.88 |
| PEG Ratio (5yr) | 1.11 |
| Price/Sales (ttm) | 0.56 |
| Price/Book (mrq) | 1.41 |
| EV/Revenue | 0.84 |
| EV/EBITDA | 5.67 |
Share Statistics
| Avg Vol (3m) | 1.07M |
| Shares Outstanding | 53.29M |
| Float | 49.60M |
| % Held by Insiders | 4.83% |
| % Held by Institutions | 101.01% |
| Short Ratio | 3.62 |
| Short % of Float | 7.92% |
Profitability
| Gross Margin | 44.61% |
| Operating Margin (ttm) | 11.14% |
| Profit Margin | 8.42% |
| Return on Assets (ttm) | 8.32% |
| Return on Equity (ttm) | 20.95% |
Income Statement
| Revenue (ttm) | 18.11B |
| Revenue Growth (yoy) | 8.30% |
| Gross Profit (ttm) | 8.08B |
| EBITDA | 2.70B |
| Net Income (ttm) | 1.53B |
| Diluted EPS (ttm) | 24.79 |
| EPS Growth (yoy) | 10.10% |
Balance Sheet
| Total Cash (mrq) | 138.80M |
| Total Debt (mrq) | 5.26B |
| Debt / Equity (mrq) | 68.74 |
| Current Ratio (mrq) | 1.12 |
| Book Value / Share | 119.15 |
| Operating CF (ttm) | 1.80B |
| Free Cash Flow (ttm) | 497.97M |
Trading & Dividends
| Beta (5Y) | 1.07 |
| 50-Day MA | 151.32 |
| 200-Day MA | 192.06 |
| Fwd Dividend Yield | 48.00% |
| Payout Ratio | 3.27% |
Ownership Breakdown
Institutional 101.01%
Insider 4.83%
Short Interest
7.92% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in UHS in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | MCDONNELL EILEEN C. | Director | Stock Award(Grant) at price 0.00 per share. | 1,217 | — |
| 2026-05-20 | NIMETZ WARREN J. | Director | Stock Award(Grant) at price 0.00 per share. | 1,217 | — |
| 2026-05-20 | SINGER MARIA RUDERMAN | Director | Stock Award(Grant) at price 0.00 per share. | 1,217 | — |
| 2026-05-20 | CHEN-LANGENMAYR NINA | Director | Stock Award(Grant) at price 0.00 per share. | 1,217 | — |
| 2026-05-20 | SUSSMAN ELLIOT M.D. | Director | Stock Award(Grant) at price 0.00 per share. | 1,217 | — |
| 2026-03-26 | FILTON STEVEN G. | Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 6,850 | — |
| 2026-03-26 | MILLER MARC D | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 29,715 | — |
| 2026-03-26 | PETERSON MATTHEW JAY | Officer | Stock Award(Grant) at price 0.00 per share. | 5,627 | — |
| 2026-03-26 | SIM EDWARD H. | Officer | Stock Award(Grant) at price 0.00 per share. | 6,404 | — |
| 2026-03-26 | MILLER ALAN B | Officer, Director and Beneficial Owner | Stock Award(Grant) at price 0.00 per share. | 14,153 | — |
| 2026-03-13 | SUSSMAN ELLIOT M.D. | Director | Conversion of Exercise of derivative security at price 138.80 per share. | 2,500 | $347,000 |
| 2026-03-13 | SUSSMAN ELLIOT M.D. | Director | Sale at price 186.35 - 193.37 per share. | 674 | $128,099 |
| 2026-03-12 | MILLER MARC D | Chief Executive Officer | Conversion of Exercise of derivative security at price 138.80 - 152.68 per share. | 100,425 | $14,638,889 |
| 2026-03-12 | SINGER MARIA RUDERMAN | Director | Conversion of Exercise of derivative security at price 138.80 per share. | 2,500 | $347,000 |
| 2026-03-12 | FILTON STEVEN G. | Chief Financial Officer | Conversion of Exercise of derivative security at price 138.80 - 152.68 per share. | 83,237 | $12,164,529 |
| 2026-03-12 | FILTON STEVEN G. | Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 16,044 | — |
| 2026-03-12 | MILLER MARC D | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 63,036 | — |
| 2026-03-12 | PETERSON MATTHEW JAY | Officer | Stock Award(Grant) at price 0.00 per share. | 13,181 | — |
| 2026-03-12 | SIM EDWARD H. | Officer | Stock Award(Grant) at price 0.00 per share. | 15,000 | — |
| 2026-03-12 | MILLER ALAN B | Officer, Director and Beneficial Owner | Stock Award(Grant) at price 0.00 per share. | 33,149 | — |
| 2026-03-10 | MILLER ALAN B | Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security at price 138.80 - 152.68 per share. | 132,712 | $19,394,968 |
| 2025-11-11 | NIMETZ WARREN J. | Director | Conversion of Exercise of derivative security at price 138.80 per share. | 10,000 | $1,388,000 |
| 2025-11-11 | NIMETZ WARREN J. | Director | Sale at price 223.28 - 223.96 per share. | 3,817 | $852,343 |
| 2025-10-29 | MILLER MARC D | Chief Executive Officer | Conversion of Exercise of derivative security at price 138.80 - 152.68 per share. | 165,000 | $24,151,200 |
| 2025-10-29 | PETERSON MATTHEW JAY | Officer | Conversion of Exercise of derivative security at price 138.80 - 152.68 per share. | 17,890 | $2,614,506 |
MCDONNELL EILEEN C.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-20
1,217 sh
—
NIMETZ WARREN J.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-20
1,217 sh
—
SINGER MARIA RUDERMAN
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-20
1,217 sh
—
CHEN-LANGENMAYR NINA
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-20
1,217 sh
—
SUSSMAN ELLIOT M.D.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-20
1,217 sh
—
FILTON STEVEN G.
Chief Financial Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-26
6,850 sh
—
MILLER MARC D
Chief Executive Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-26
29,715 sh
—
PETERSON MATTHEW JAY
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-26
5,627 sh
—
SIM EDWARD H.
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-26
6,404 sh
—
MILLER ALAN B
Officer, Director and Beneficial Owner
Stock Award(Grant) at price 0.00 per share.
2026-03-26
14,153 sh
—
SUSSMAN ELLIOT M.D.
Director
Conversion of Exercise of derivative security at price 138.80 per share.
2026-03-13
2,500 sh
$347,000
SUSSMAN ELLIOT M.D.
Director
Sale at price 186.35 - 193.37 per share.
2026-03-13
674 sh
$128,099
MILLER MARC D
Chief Executive Officer
Conversion of Exercise of derivative security at price 138.80 - 152.68 per share.
2026-03-12
100,425 sh
$14,638,889
SINGER MARIA RUDERMAN
Director
Conversion of Exercise of derivative security at price 138.80 per share.
2026-03-12
2,500 sh
$347,000
FILTON STEVEN G.
Chief Financial Officer
Conversion of Exercise of derivative security at price 138.80 - 152.68 per share.
2026-03-12
83,237 sh
$12,164,529
FILTON STEVEN G.
Chief Financial Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-12
16,044 sh
—
MILLER MARC D
Chief Executive Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-12
63,036 sh
—
PETERSON MATTHEW JAY
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-12
13,181 sh
—
SIM EDWARD H.
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-12
15,000 sh
—
MILLER ALAN B
Officer, Director and Beneficial Owner
Stock Award(Grant) at price 0.00 per share.
2026-03-12
33,149 sh
—
MILLER ALAN B
Officer, Director and Beneficial Owner
Conversion of Exercise of derivative security at price 138.80 - 152.68 per share.
2026-03-10
132,712 sh
$19,394,968
NIMETZ WARREN J.
Director
Conversion of Exercise of derivative security at price 138.80 per share.
2025-11-11
10,000 sh
$1,388,000
NIMETZ WARREN J.
Director
Sale at price 223.28 - 223.96 per share.
2025-11-11
3,817 sh
$852,343
MILLER MARC D
Chief Executive Officer
Conversion of Exercise of derivative security at price 138.80 - 152.68 per share.
2025-10-29
165,000 sh
$24,151,200
PETERSON MATTHEW JAY
Officer
Conversion of Exercise of derivative security at price 138.80 - 152.68 per share.
2025-10-29
17,890 sh
$2,614,506